Evidence map›Paper›PMID 42084374›Full record

ReviewmBio2026

mGem: More than building blocks? Mitochondrial metabolism, viruses, and the host response to infection.

Jessica Alvarez, Dustin C Hancks

Abstract readReview
In one paragraph

Review in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jessica AlvarezMolecular Microbiology Ph.D. program, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0009-0008-4436-1402
Dustin C HancksDepartment of Immunology, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0003-2720-2545

Funding

MOLECULAR MICROBIOLOGY TRAINING GRANTT32AI007520 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Julie K Pfeiffer · 1997 to 2026
$7.0M
Evolution-guided Studies of Mitochondrial FunctionsR35GM142689 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI HANCKS, DUSTIN · 2021 to 2025
$2.0M
NIAID NIH HHS T32 AI007520NIGMS NIH HHS R35 GM142689
6 · The paper itself

Abstract

Beyond essential roles as central hubs integrating homeostatic cellular metabolism, mitochondria have emerged as critical determinants of infection outcomes. Mitochondrial activities, like MAVS signaling and the release of cytochrome c and mitochondrial DNA, drive host defenses. Across cell types, mitochondrial metabolism and antiviral responses are also increasingly being connected by evidence such as viral-encoded antagonists. Nonetheless, metabolic rewiring in infected cells is still largely viewed as a means to satisfy biosynthetic demands for both viral replication and the host response. However, perturbation of metabolic states within infected and bystander cells seemingly has consequences for outcomes, implying an incompletely understood metabo-immunoregulatory logic. Here, we consider roles for mitochondrial metabolism reprogramming as an active cue that licenses progressive immune states to adapt host responses. In the coming years, integration of mitochondrial biology and new methodologies, including spatial approaches, will illuminate the interplay of mitochondrial metabolism on primary antiviral responses.

Indexed as

Host-Pathogen InteractionsMitochondriaVirus DiseasesVirusesAnimalsHumansMetabolic ReprogrammingSignal TransductionVirus Replicationimmune responseimmunometabolismmitochondriamitochondrial dysfunctionOXPHOSsterile inflammationviral infection

Identifiers

PMID42084374
PMCPMC13251384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.